Skip to main content

Advertisement

Log in

Risk-stratification of thyroid nodules examined by 18FDG-PET/CT while ensuring congruity between imaging and histopathological localization

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The risk of malignancy (ROM) in FDG-avid thyroid incidentalomas varies between studies, which may be contributed by discordance between the anatomical localization depicted on 18FDG-PET/CT and by histopathological examination. The purpose was to ensure anatomical congruity between the index tumour identified by 18FDG-PET/CT and the histopathological examination, in order to assess the risk of malignancy (ROM) in PET-positive and PET-negative thyroid nodules. Further, preoperative characteristics indicative of thyroid malignancy were identified.

Methods

Thirty-two patients referred to thyroid surgery were prospectively included. 18FDG-PET/CT, fine-needle aspiration biopsy and thyroid ultrasonography examination were performed in all participants. The exact anatomical localization of the index nodule was established by histopathological examination to ensure concordance with the 18FDG-PET/CT finding.

Results

Forty thyroid nodules were included. Malignancy was identified in 10 of 28 PET-positive nodules and in 1 of 12 PET-negative nodules, resulting in a ROM of 36% and 8%, respectively. A Hurtle cell neoplasm was found in 50% of patients with a benign nodule and a PET-positive scan. One PET-negative nodule represented a papillary microcarcinoma. In PET-positive nodules, hypoechogenicity, irregular margins, and pathological lymph nodes on thyroid ultrasonography were characteristics associated with malignancy.

Conclusions

In this study—ensuring anatomical congruity between PET-findings and the histopathological examination—the risk of malignancy in PET-positive thyroid nodules was 36%. A low ROM was seen in thyroid nodules without suspicious ultrasonographic findings, independent of the 18FDG-PET/CT result.

Trial registration number

NCT02150772 registered 14th of April 2014.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The data is not available in public databases due to Danish legislation.

References

  1. Hegedus L (2004) Clinical practice The thyroid nodule. N Engl J Med 351(17):1764–71

    Article  Google Scholar 

  2. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H (2000) Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol 53(4):479–485

    Article  CAS  Google Scholar 

  3. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167

    Article  CAS  Google Scholar 

  4. Blomberg M, Feldt-Rasmussen U, Andersen KK, Kjaer SK (2012) Thyroid cancer in Denmark 1943–2008, before and after iodine supplementation. Int J Cancer 131(10):2360–2366

    Article  CAS  Google Scholar 

  5. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28–35

    Article  Google Scholar 

  6. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 56(4):333–339

    Article  Google Scholar 

  7. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A (2009) Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 30(9):742–748

    Article  Google Scholar 

  8. Soelberg KK, Bonnema SJ, Brix TH, Hegedus L (2012) Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22(9):918–925

    Article  CAS  Google Scholar 

  9. Bertagna F, Treglia G, Piccardo A, Giubbini R (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 97(11):3866–3875

    Article  CAS  Google Scholar 

  10. Nayan S, Ramakrishna J, Gupta MK (2014) The proportion of malignancy in incidental thyroid lesions on 18-FDG PET Study: a systematic review and meta-analysis. Otolaryngology Head Neck Surg. 151(2):190–200

    Article  Google Scholar 

  11. Swan KZ, Bonnema SJ, Jespersen ML, Nielsen VE (2019) Reappraisal of shear wave elastography as a diagnostic tool for identifying thyroid carcinoma. Endocrine Connect 8(8):1195–1205

    Article  CAS  Google Scholar 

  12. Society TDE. National guideline: Examination of the nodule in the thyroid gland 2017 [Available from: http://www.endocrinology.dk/index.php/2-thyroidea-sygdomme/nbv-endokrinologi-udredning-af-knuden-i-glandula-thyreoidea-thyreoideacyste-thyreoditis-thyreoideabiopsi-tumor-i-skoldbruskkirtlen.

  13. Russ G, Royer B, Bigorgne C, Rouxel A, Bienvenu-Perrard M, Leenhardt L (2013) Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography. Eur J Endocrinol 168(5):649–655

    Article  CAS  Google Scholar 

  14. Cibas ES, Ali SZ (2009) The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 132(5):658–665

    Article  Google Scholar 

  15. Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F et al (2010) Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg 34(6):1247–1253

    Article  Google Scholar 

  16. Hales NW, Krempl GA, Medina JE (2008) Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol 29(2):113–118

    Article  Google Scholar 

  17. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L et al (2012) Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22(2):165–172

    Article  CAS  Google Scholar 

  18. Buyukdereli G, Aktar Y, Kara E, Uguz A, Sonmez H (2016) Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules. Iranian J Radiol 13(1):e21186

    Article  Google Scholar 

  19. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF (2011) The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117(20):4582–4594

    Article  Google Scholar 

  20. Wang N, Zhai H, Lu Y (2013) Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J otolaryngol Head Neck Surg = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 42:38

  21. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I et al (2003) Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133(3):294–299

    Article  Google Scholar 

  22. Pathak KA, Klonisch T, Nason RW, Leslie WD (2016) FDG-PET characteristics of Hurthle cell and follicular adenomas. Ann Nucl Med 30(7):506–509

    Article  CAS  Google Scholar 

  23. Ito Y, Miyauchi A, Oda H (2018) Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials. Eur J Surg Oncol 44(3):307–315

    Article  CAS  Google Scholar 

  24. Piccardo A, Trimboli P, Foppiani L, Treglia G, Ferrarazzo G, Massollo M et al (2019) PET/CT in thyroid nodule and differentiated thyroid cancer patients The evidence-based state of the art. Rev Endocr Metab Disord. 20(1):47–64

    Article  Google Scholar 

  25. Agarwal S, Bychkov A, Jung CK, Hirokawa M, Lai CR, Hong S et al (2019) The prevalence and surgical outcomes of Hurthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries. Cancer Cytopathol 127(3):181–191

    Article  CAS  Google Scholar 

  26. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L (2017) European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid Jal 6(5):225–237

    Article  Google Scholar 

  27. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133

    Article  Google Scholar 

  28. Beech P, Lavender I, Jong I, Soo G, Ramdave S, Chong A et al (2016) Ultrasound stratification of the FDG-avid thyroid nodule. Clin Radiol 71(2):164–169

    Article  CAS  Google Scholar 

Download references

Funding

The project was supported financially by Fonden af 17-12-1981 (Copenhagen, Denmark) (Grant for KZS), Aarhus University (Aarhus, Denmark) (Grant for KZS) and by the Central Denmark Region (Denmark) (funding for equipment).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kristine Zøylner Swan.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethics approval

The study was conducted in accordance with the World Medical Association Declaration of Helsinki. The study protocol was approved by the Ethical Committee of the Central Denmark Region, and registered at The Danish Data Protection Agency and on Clinicaltrials.gov (NCT02150772).

Consent to participate

All participants gave written informed consent before inclusion in the study.

Consent for publication

Included patients gave written informed consent for results to be published anonymously.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bakkegaard, P., Londero, S.C., Bonnema, S.J. et al. Risk-stratification of thyroid nodules examined by 18FDG-PET/CT while ensuring congruity between imaging and histopathological localization. Eur Arch Otorhinolaryngol 278, 4979–4985 (2021). https://doi.org/10.1007/s00405-021-06733-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06733-5

Keywords

Navigation